BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang X, Ding H, Li Z, Peng Y, Tan H, Wang C, Huang G, Li W, Ma G, Wei W. Exploration and functionalization of M1-macrophage extracellular vesicles for effective accumulation in glioblastoma and strong synergistic therapeutic effects. Signal Transduct Target Ther 2022;7:74. [PMID: 35292619 DOI: 10.1038/s41392-022-00894-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Kalluri AL, Shah PP, Lim M. The Tumor Immune Microenvironment in Primary CNS Neoplasms: A Review of Current Knowledge and Therapeutic Approaches. IJMS 2023;24:2020. [DOI: 10.3390/ijms24032020] [Reference Citation Analysis]
2 Jiang J, Huang Y, Zeng Z, Zhao C. Harnessing Engineered Immune Cells and Bacteria as Drug Carriers for Cancer Immunotherapy. ACS Nano 2023. [PMID: 36598956 DOI: 10.1021/acsnano.2c07607] [Reference Citation Analysis]
3 Khan F, Pang L, Dunterman M, Lesniak MS, Heimberger AB, Chen P. Macrophages and microglia in glioblastoma: heterogeneity, plasticity, and therapy. J Clin Invest 2023;133. [PMID: 36594466 DOI: 10.1172/JCI163446] [Reference Citation Analysis]
4 Wang S, Shi Y. Exosomes Derived from Immune Cells: The New Role of Tumor Immune Microenvironment and Tumor Therapy. Int J Nanomedicine 2022;17:6527-50. [PMID: 36575698 DOI: 10.2147/IJN.S388604] [Reference Citation Analysis]
5 Lou K, Feng S, Luo H, Zou J, Zhang G, Zou X. Extracellular vesicles derived from macrophages: Current applications and prospects in tumors. Front Bioeng Biotechnol 2022;10:1097074. [PMID: 36588947 DOI: 10.3389/fbioe.2022.1097074] [Reference Citation Analysis]
6 Zhang Y, Wu W, Pan X, Wang Y, Wu C, Lu L, Yu X, Li Y. Extracellular vesicles as novel therapeutic targets and diagnosis markers. Extracellular Vesicle 2022;1:100017. [DOI: 10.1016/j.vesic.2022.100017] [Reference Citation Analysis]
7 Lim C, Koo J, Oh KT. Nanomedicine approaches for medulloblastoma therapy. J Pharm Investig 2022. [DOI: 10.1007/s40005-022-00597-5] [Reference Citation Analysis]
8 Silver A, Feier D, Ghosh T, Rahman M, Huang J, Sarkisian MR, Deleyrolle LP. Heterogeneity of glioblastoma stem cells in the context of the immune microenvironment and geospatial organization. Front Oncol 2022;12:1022716. [PMID: 36338705 DOI: 10.3389/fonc.2022.1022716] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Wang Z, Zhong H, Liang X, Ni S. Targeting tumor-associated macrophages for the immunotherapy of glioblastoma: Navigating the clinical and translational landscape. Front Immunol 2022;13:1024921. [DOI: 10.3389/fimmu.2022.1024921] [Reference Citation Analysis]
10 Wu J, Ma L, Sun D, Zhang X, Cui J, Du Y, Guo Y, Wang X, Di L, Wang R. Bioengineering extracellular vesicles as novel nanocarriers towards brain disorders. Nano Res . [DOI: 10.1007/s12274-022-4913-2] [Reference Citation Analysis]
11 Barone A, d’Avanzo N, Cristiano MC, Paolino D, Fresta M. Macrophage-Derived Extracellular Vesicles: A Promising Tool for Personalized Cancer Therapy. Biomedicines 2022;10:1252. [DOI: 10.3390/biomedicines10061252] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]